Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Steven Bradley to Coronary Artery Disease

This is a "connection" page, showing publications Steven Bradley has written about Coronary Artery Disease.

 
Connection Strength
  
 
 
4.868
  
  1. Bradley SM, Gluckman TJ. If the Fates Allow: The Zero-Sum Game of ISCHEMIA-EXTEND. Circulation. 2023 01 03; 147(1):20-22.
    View in: PubMed
    Score: 0.563
  2. Bradley SM, Kaltenbach LA, Xiang K, Amin AP, Hess PL, Maddox TM, Poulose A, Brilakis ES, Sorajja P, Ho PM, Rao SV. Trends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2021 08 09; 14(15):1655-1666.
    View in: PubMed
    Score: 0.517
  3. Kini V, Hess PL, Liu W, Grunwald G, Ho PM, Bradley SM. Association Between Elective Percutaneous Coronary Intervention Appropriateness and Publicly Reported Outcomes. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e007421.
    View in: PubMed
    Score: 0.491
  4. Hess PL, Kini V, Liu W, Roldan P, Autruong P, Grunwald GK, O'Donnell C, Doll JA, Ho PM, Bradley SM. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015. JAMA Netw Open. 2020 04 01; 3(4):e203144.
    View in: PubMed
    Score: 0.470
  5. Bradley SM, Hess E, Winchester DE, Sussman JB, Aggarwal V, Maddox TM, Bar?n AE, Rumsfeld JS, Ho PM. Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2015 Sep; 8(5):486-92.
    View in: PubMed
    Score: 0.340
  6. Bradley SM, Chan PS, Hartigan PM, Nallamothu BK, Weintraub WS, Sedlis SP, Dada M, Maron DJ, Kostuk WJ, Berman DS, Teo KK, Mancini GB, Boden WE, Spertus JA. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial). Am J Cardiol. 2015 Jul 15; 116(2):167-73.
    View in: PubMed
    Score: 0.333
  7. Bradley SM, Stanislawski MA, Bekelman DB, Monteith LL, Cohen BE, Schilling JH, Hunt SC, Milek D, Maddox TM, Ho PM, Shore S, Varosy PD, Matthieu MM, Rumsfeld JS. Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Am Heart J. 2014 Sep; 168(3):381-390.e6.
    View in: PubMed
    Score: 0.314
  8. Bradley SM, Maynard C, Bryson CL. Appropriateness of percutaneous coronary interventions in Washington State. Circ Cardiovasc Qual Outcomes. 2012 Jul 01; 5(4):445-53.
    View in: PubMed
    Score: 0.272
  9. Bradley SM, Bryson CL, Maynard C, Maddox TM, Fihn SD. Recent hospitalization for non-coronary events and use of preventive medications for coronary artery disease: an observational cohort study. BMC Cardiovasc Disord. 2011 Jul 09; 11:42.
    View in: PubMed
    Score: 0.257
  10. Kini V, Parks M, Liu W, Waldo SW, Ho PM, Bradley SM, Hess PL. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 06 01; 5(6):e2217704.
    View in: PubMed
    Score: 0.137
  11. Kini V, Mosley B, Raghavan S, Khazanie P, Bradley SM, Magid DJ, Ho PM, Masoudi FA. Differences in High- and Low-Value Cardiovascular Testing by Health Insurance Provider. J Am Heart Assoc. 2021 02 02; 10(3):e018877.
    View in: PubMed
    Score: 0.125
  12. Lowenstern A, Wu J, Bradley SM, Fanaroff AC, Tcheng JE, Wang TY. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Am Heart J. 2019 09; 215:167-177.
    View in: PubMed
    Score: 0.112
  13. Bradley SM, Borgerding JA, Wood GB, Maynard C, Fihn SD. Incidence, Risk Factors, and Outcomes Associated With In-Hospital Acute Myocardial Infarction. JAMA Netw Open. 2019 01 04; 2(1):e187348.
    View in: PubMed
    Score: 0.108
  14. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.105
  15. Raghavan S, Liu WG, Michael Ho P, Plomondon ME, Bar?n AE, Caplan L, Joynt Maddox KE, Magid D, Saxon DR, Voils CI, Bradley SM, Maddox TM. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction. J Diabetes Complications. 2018 05; 32(5):480-487.
    View in: PubMed
    Score: 0.101
  16. Kobayashi T, Glorioso TJ, Armstrong EJ, Maddox TM, Plomondon ME, Grunwald GK, Bradley SM, Tsai TT, Waldo SW, Rao SV, Banerjee S, Nallamothu BK, Bhatt DL, Rene AG, Wilensky RL, Groeneveld PW, Giri J. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. JAMA Cardiol. 2017 09 01; 2(9):967-975.
    View in: PubMed
    Score: 0.098
  17. Valle JA, O'Donnell CI, Armstrong EJ, Bradley SM, Maddox TM, Ho PM. Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. J Am Heart Assoc. 2016 05 16; 5(5).
    View in: PubMed
    Score: 0.090
  18. Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016 Sep 06; 134(10):e156-78.
    View in: PubMed
    Score: 0.089
  19. Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary?Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1116-39.
    View in: PubMed
    Score: 0.089
  20. Winchester DE, Kitchen A, Brandt JC, Dusaj RS, Virani SS, Bradley SM, Shaw LJ, Beyth RJ. Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clin Cardiol. 2015 Apr; 38(4):195-9.
    View in: PubMed
    Score: 0.083
  21. Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014 Nov 05; 312(17):1754-63.
    View in: PubMed
    Score: 0.081
  22. Maddox TM, Chan PS, Spertus JA, Tang F, Jones P, Ho PM, Bradley SM, Tsai TT, Bhatt DL, Peterson PN. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Feb 18; 63(6):539-46.
    View in: PubMed
    Score: 0.075
  23. Vigen R, O'Donnell CI, Bar?n AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013 Nov 06; 310(17):1829-36.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)